Health economic models in hemophilia A and utility assumptions from a clinician's perspective.

about

Personalized prophylaxis in people with hemophilia A: challenges and achievements.Modern Treatments of Haemophilia: Review of Cost-Effectiveness Analyses and Future Directions.An innovative outcome-based care and procurement model of hemophilia management.

P2860

Q38997467-865B6B33-519E-4CB5-BE1A-2F83087DE9FB Q45874959-A5668F1F-9FAC-4A6D-9BA5-F62119959FD5 Q45884983-3951708B-ADB1-4480-BD05-40D9D0460E52

P2860

Health economic models in hemophilia A and utility assumptions from a clinician's perspective.

Item

http://www.wikidata.org/entity/Q40938357

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Health economic models in hemo ...... rom a clinician's perspective.

@en

type

Item

label

Health economic models in hemo ...... rom a clinician's perspective.

@en

prefLabel

Health economic models in hemo ...... rom a clinician's perspective.

@en

P1476

Health economic models in hemo ...... rom a clinician's perspective.

@en

P2093

Giuseppe Lassandro

http://www.w3.org/2001/XMLSchema#string

Jennifer Pocoski

http://www.w3.org/2001/XMLSchema#string

Michele Valente

http://www.w3.org/2001/XMLSchema#string

Prasad Mathew

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibitor development in previously treated hemophilia A patients: a systematic review, meta-analysis, and meta-regression.

Haemophilias A and B.

Cost-utility analysis of prophylaxis versus treatment on demand in severe hemophilia A

Quality of life assessment in clinical practice in haemophilia treatment.

Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A.

Prophylactic therapy in haemophilia.

The European Principles of Haemophilia Care: a pilot investigation of adherence to the principles in Europe.

Economic evaluations of prophylaxis with clotting factor for people with severe haemophilia: why do the results vary so much?

The burden of bleeding in haemophilia: is one bleed too many?

Assessing health-related quality-of-life in individuals with haemophilia.

P304

1826-1831

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.25543

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paola Giordano

Lorenzo G. Mantovani

Paolo A. Cortesi

Angelo Claudio Molinari

P577

2015-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276295919

http://www.w3.org/2001/XMLSchema#string

P698

25976056

http://www.w3.org/2001/XMLSchema#string

P921

hemophilia

hemophilia A

Health economic models in hemophilia A and utility assumptions from a clinician's perspective.

about

P2860

P2860

Health economic models in hemophilia A and utility assumptions from a clinician's perspective.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921